Europe Injectable Drug Delivery Market

Europe Injectable Drug Delivery Market Outlook

The Europe Injectable Drug Delivery Market size was valued at USD 262.45 Billion in 2022 and is expected to surpass USD 763.65 Billion by 2031, expanding at a CAGR of 12.6% during the forecast period, 2023–2031. The growth of the market is attributed to increasing use of biologics.

Injectable drug delivery system is infusion method, which allocates drug into body by piercing the syringe attached to the needle. Injectable drug delivery systems are well known and highly accepted due to their rapid action with the high effectiveness. Most preferred route includes intravenous (IV), subcutaneous (SC), and Intramuscular (IM).

Get Free Sample Report

The COVID-19 pandemic positively impacted the injectable drug delivery market due to various pharmaceutical companies have started revising their packaging and sterilization suppliers in order to update their offerings.

Europe Injectable Drug Delivery Market Trends, Drivers, Restraints, and Opportunities

• Rising patients interest from vial and syringe to ready to use (pre-filled) delivery system is projected to boost the market growth in the coming years.

• Increasing incidence of chronic diseases is anticipated to the market growth during the forecast period.

• Growing management of product life cycle and advanced technologies is estimated to spur the market growth in the coming years.

• Rising demand for vaccines, insulin, human growth hormone, and modern medicines is anticipated to drive the market growth during the forecast period.

• Increasing consumer awareness across the region is projected to boost the market growth in the coming years.

• Growing use of the systems and devices in administering drugs in unconscious and comatose patients and rise in partnerships, collaborations and acquisitions are estimated to spur the market growth in the coming years.

• Rising health consciousness among consumers and investments to improve healthcare system are projected to boost the market growth in the coming years.

• Growing geriatric population is anticipated to the market growth during the forecast period.

• High number of needle stick injuries is estimated to restrict the market growth.

• Contraceptive injectable preference for other mode of drug delivery can create challenges for the market.

• Advancements in nanotechnology and others extend profitable has led to new opportunities in the market.

Scope of Europe Injectable Drug Delivery Market Report

The report on the Europe injectable drug delivery market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Europe Injectable Drug Delivery Market Segment Insights

Conventional drug delivery devices segment to hold a significant market share

On the basis of device types, the market is divided into conventional drug delivery devices and self-injectable drug delivery devices. The self-injectable drug delivery devices segment is segregated into prefilled syringes, injectable pens, auto injectors, needle-free injectors, and others.

The self-injectable drug delivery devices segment is anticipated to hold a key share of the market in the coming years due to advantages of self-injectable injections and increasing awareness of self-administration.

However, the conventional drug delivery devices segment is anticipated to expand at a rapid pace during the forecast period due to reducing volume of distribution of drugs.

Get Free Sample Report

Oncology segment is projected to expand at a considerable CAGR

Based on therapeutic applications, the market is segregated into cardiovascular disease, diabetes, oncology, autoimmune disorders, hepatitis, and others. The cardiovascular disease segment is expected to represent a key share of the market in the upcoming years.

On the other hand, the oncology segment is anticipated to expand at a rapid pace during the forecast period owning to requirement for better cancer detection solutions.

Get Free Sample Report

Europe Injectable Drug Delivery Market Regional Outlook

The UK is estimated to account a major market share

On the basis of regions, the Europe injectable drug delivery market is classified as Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany is expected to constitute a key share of the market during the projected period due to growing healthcare expenditure and technological advances. However, the market in the UK is anticipated expand at a rapid pace during the forecast period.

Segments

Device Types

• Conventional Drug Delivery Devices
• Self-injectable Drug Delivery Devices
  • Prefilled Syringes
  • Injectable Pens
  • Auto Injectors
  • Needle-free Injectors
  • Others

Therapeutic Applications

• Cardiovascular Disease
• Diabetes
• Oncology
• Autoimmune Disorders
• Hepatitis
• Others

Geography

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Key Players

• Baxter International
• Becton
• Dickinson and Company
• Eli Lilly and Company
• Gerresheimer AG
• Novo Nordisk
• Pfizer
• Schott AG
• Terumo Corporation
• Teva Pharmaceutical Industries
• West Pharmaceutical Services Inc.

Competitive Landscape

Key players competing in the Europe injectables drug delivery market includes Baxter International; Becton; Dickinson and Company; Eli Lilly and Company; Gerresheimer AG; Novo Nordisk; Pfizer; Schott AG; Terumo Corporation; Teva Pharmaceutical Industries; and West Pharmaceutical Services Inc.

Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.